Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)

Grande, E.; Capdevila, J.; Castellano, D.; Teulé, A.; Durán, I.; Fuster, J.; Sevilla, I.; Escudero, P.; Sastre, J.; García-Donas, J.; Casanovas, O.; Earl, J.; Ortega, L.; Apellaniz-Ruiz, M.; Rodriguez-Antona, C.; Alonso-Gordoa, T.; Díez, J. J.; Carrato, A.; García-Carbonero, R.

Published in

Elsevier, Annals of Oncology, 9(26), p. 1987-1993, 2015

DOI: 10.1093/annonc/mdv252

Tools

Export citation

Search in Google Scholar

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)

Journal article published in 2015 by E. Grande, J. Capdevila, D. Castellano, A. Teulé, I. Durán, J. Fuster, I. Sevilla, P. Escudero, J. Sastre, J. García-Donas

, O. Casanovas, J. Earl, L. Ortega, M. Apellaniz-Ruiz

, C. Rodriguez-Antona and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by

Published in

Links

Tools

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)